Wall Street Zen Downgrades Xylem (NYSE:XYL) to Hold

Xylem (NYSE:XYL) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

A number of other analysts have also commented on the company. Barclays boosted their price target on Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. Mizuho set a $160.00 target price on Xylem in a research report on Wednesday, October 29th. Robert W. Baird set a $178.00 target price on Xylem in a research note on Wednesday, October 29th. Royal Bank Of Canada raised their price target on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Finally, Stifel Nicolaus lifted their price objective on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $167.40.

Xylem Stock Performance

Shares of XYL stock opened at $138.84 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. Xylem has a 52 week low of $100.47 and a 52 week high of $154.27. The company’s 50 day moving average price is $143.20 and its two-hundred day moving average price is $139.77. The company has a market capitalization of $33.80 billion, a P/E ratio of 35.69, a price-to-earnings-growth ratio of 2.15 and a beta of 1.18.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The company had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. During the same quarter in the prior year, the firm earned $1.11 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, analysts expect that Xylem will post 4.65 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director directly owned 16,875 shares in the company, valued at $2,499,862.50. The trade was a 9.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.27% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Xylem

Several large investors have recently modified their holdings of XYL. SJS Investment Consulting Inc. boosted its holdings in shares of Xylem by 1,844.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock worth $26,000 after buying an additional 166 shares during the period. Knuff & Co LLC acquired a new stake in Xylem during the third quarter worth approximately $27,000. Wexford Capital LP bought a new stake in shares of Xylem during the third quarter worth approximately $27,000. First Horizon Corp bought a new stake in shares of Xylem during the third quarter worth approximately $30,000. Finally, Ramirez Asset Management Inc. grew its position in shares of Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after purchasing an additional 100 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.